Company intelligence / Profile preview

Daymark Health

Philadelphia, Pennsylvania, United Statesdaymarkhealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Daymark Health has launched a value-based oncology platform delivering comprehensive supportive and palliative cancer care. Its model integrates clinical, mental health, and social needs through virtual and in-home visits. Early operations began in 2025 with over 2,500 patients served via payer partnerships. The approach emphasizes continuous symptom management, advanced illness conversations, education about disease understanding/goals of care, and wraparound support.

Therapeutic areas: Oncology
Modalities: Non-pharmacological therapy (care navigation, symptom management, mental health support)Telehealth servicesIn-home supportive care
Industry: Non-Academic Healthcare

Partnerships

Leading payer(s) in the Northeast US for initial launch

Beyond the preview

Go deeper on Daymark Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daymark Health.

Explore the full profile